Healthcare

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...

While the United States and Europe medical device markets face backlash from the economic slowdown, the Russia-Ukraine war, and the cost-of-living crisis, the APAC medical devices market continues to record phenomenal growth. However, 2023 will be challenging for APAC medtech due to uncertainties arising from the anticipated market slowdown and oth...

The Asia-Pacific medical imaging and informatics market revenue is forecast to increase by 11.4% in 2023, mainly driven by the high procurement of medical imaging equipment and radiology IT solutions in the informatics sector. Large hospitals widely adopt digital radiography and ultrasound systems as the devices are operator-dependent and need a sk...

06 Apr 2023  |  Asia Pacific

Asia-Pacific Digital Health Outlook, 2023

Health Inequity, Workforce Shortage, and Aging Population will Lead to Transformational Growth of Virtual Health Technologies

Infographics

×

Key Issues Addressed

The average physician-to-population ratio, high healthcare demand, rising aging population, and healthcare cost pressure have driven APAC’s digital health market, making it the most lucrative growth destination. Telehealth and virtual care segments witnessed exponential growth with their critical role in addressing healthcare challenges and consu...

05 Apr 2023  |  Asia Pacific

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japa...

In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...

The study covers the healthcare market which develops and provides products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. The biosimilars market in India is expected to cross $0.9 billion by 2020. The growing prevalence of chronic diseases with an increasing aged population in India and globally, c...

30 Apr 2020  |  Asia Pacific

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

Infographics

×

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...